Invention Grant
- Patent Title: Methods for treating liver disorders using FXR agonists
-
Application No.: US16078409Application Date: 2017-02-20
-
Publication No.: US11344540B2Publication Date: 2022-05-31
- Inventor: Bryan Laffitte , Michael Badman , Jin Chen , Sam Lindgren
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Emily T. Wu
- International Application: PCT/IB2017/050963 WO 20170220
- International Announcement: WO2017/145041 WO 20170831
- Main IPC: A61K31/46
- IPC: A61K31/46 ; A61P1/12 ; A61K31/506 ; A61K31/497 ; A61K31/4748 ; A61K47/54 ; A61P1/16 ; A61K9/00
Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver diseases.
Public/Granted literature
- US20190046519A1 METHODS FOR USING FXR AGONISTS Public/Granted day:2019-02-14
Information query
